Copyright
©The Author(s) 2022.
World J Crit Care Med. Jan 9, 2022; 11(1): 48-57
Published online Jan 9, 2022. doi: 10.5492/wjccm.v11.i1.48
Published online Jan 9, 2022. doi: 10.5492/wjccm.v11.i1.48
Figure 1 Flow chart outlining patient selection.
SARS-CoV-2: Severe acute respiratory syndrome- coronavirus 1; COVID-19: Corona virus disease 2019; CKD: Chronic kidney disease; HD: Hemodialysis.
- Citation: Selvaraj V, Lal A, Finn A, Tanzer JR, Baig M, Jindal A, Dapaah-Afriyie K, Bayliss G. Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease. World J Crit Care Med 2022; 11(1): 48-57
- URL: https://www.wjgnet.com/2220-3141/full/v11/i1/48.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v11.i1.48